BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs3825942
,
FABP1
,
Angiogenesis
,
Allergy to pollen
,
Prostate
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interferon receptor II
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Drug target sets for approved compounds
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity…
IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19.
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arcti…
Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.
Null IFNAR1 and IFNAR2 alleles are surprisingly common in the Pacific and Arctic.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Genetic and Biochemical Markers of Interferon-Induced Depression.
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Can…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ